4.3 Review

Integrating Genetic Structural Variations and Whole-Genome Sequencing Into Clinical Neurology

期刊

NEUROLOGY-GENETICS
卷 8, 期 4, 页码 -

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/NXG.0000000000200005

关键词

-

资金

  1. MS Research Australia
  2. Medical Research Future Fund
  3. Australian National Health and Medical Research Council [GNT1173155]
  4. Mater Foundation

向作者/读者索取更多资源

Advancements in genome sequencing technologies have opened up new possibilities in understanding neurologic diseases and improving diagnostic and management strategies. Whole-genome sequencing (WGS) is a valuable tool in discovering structural variants and improving genetic tests in clinical settings. Ongoing research in structural variations and mutational constraints can contribute to improved variant interpretation and therapeutic development.
Advances in genome sequencing technologies have unlocked new possibilities in identifying disease-associated and causative genetic markers, which may in turn enhance disease diagnosis and improve prognostication and management strategies. With the capability of examining genetic variations ranging from single-nucleotide mutations to large structural variants, whole-genome sequencing (WGS) is an increasingly adopted approach to dissect the complex genetic architecture of neurologic diseases. There is emerging evidence for different structural variants and their roles in major neurologic and neurodevelopmental diseases. This review first describes different structural variants and their implicated roles in major neurologic and neurodevelopmental diseases, and then discusses the clinical relevance of WGS applications in neurology. Notably, WGS-based detection of structural variants has shown promising potential in enhancing diagnostic power of genetic tests in clinical settings. Ongoing WGS-based research in structural variations and quantifying mutational constraints can also yield clinical benefits by improving variant interpretation and disease diagnosis, while supporting biomarker discovery and therapeutic development. As a result, wider integration of WGS technologies into health care will likely increase diagnostic yields in difficult-to-diagnose conditions and define potential therapeutic targets or intervention points for genome-editing strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据